The market is rapidly transitioning from episodic diagnostics to continuous health monitoring. By 2035, the integration of ...

By the early 1950s, the company added an additional plant and bought nearly 50 million pounds of milk each year. The Harrison ...

As the restaurant development program concludes its nearly five-year run, Fishers will welcome a chef with Food Network flare ...

Danny, 11, is eight years younger than his mom was when she became the third woman and the youngest at 19 to race in the ...

FISHERS, Ind. — A Fishers woman admitted to police that she set a house on fire and stabbed herself. On Saturday, Fishers police and the Fishers Fire Department responded to a residential fire in the ...

Abbott is getting into cancer testing with its $21 billion acquisition Exact Sciences, the maker of the game-changing colorectal cancer test Cologuard. Abbott markets well-known diagnostics for ...

Abbott made a takeover offer for Exact Sciences. The two companies want to team up to combat cancer. Under the terms of the deal, Exact Sciences' stockholders would receive $105 per share in cash. The ...

Abbott announced on Thursday, Nov. 20 it plans to buy Exact Sciences, a Madison-based maker of cancer screening and diagnostic tests, in a deal valued at an estimated $23 billion, including debt. The ...

Abbott to buy Exact Sciences in $23 billion deal Exact's flagship colorectal cancer test to join Abbott's portfolio Abbott eyes international expansion for Exact's tests Aims for broad reimbursement ...

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Abbott Laboratories $21 billion deal to acquire cancer test maker Exact ...

Abbott is acquiring Exact Sciences for $23 billion, the global healthcare leader announced on Thursday. Exact Sciences shareholders will receive $105 per common share, totaling approximately $21 ...